XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 104 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q2 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $15,737 | -12.6% | 11,832 | +0.9% | 0.00% | 0.0% |
Q3 2022 | $18,000 | 0.0% | 11,732 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $18,000 | -40.0% | 11,732 | +1.6% | 0.00% | 0.0% |
Q1 2022 | $30,000 | -11.8% | 11,550 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $34,000 | – | 11,550 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 5,641,920 | $14,781,830 | 42.66% |
Stonepine Capital Management, LLC | 5,500,228 | $14,410,597 | 5.20% |
MPM BioImpact LLC | 3,974,999 | $10,414,497 | 2.10% |
Soleus Capital Management, L.P. | 2,054,105 | $5,381,755 | 0.60% |
EAM Investors, LLC | 757,962 | $1,985,860 | 0.37% |
DELTEC ASSET MANAGEMENT LLC | 406,190 | $1,064,218 | 0.23% |
Alpine Global Management, LLC | 225,000 | $589,500 | 0.18% |
Redmile Group, LLC | 1,046,587 | $2,742,058 | 0.10% |
IHT Wealth Management, LLC | 281,442 | $737,379 | 0.04% |
OCCUDO QUANTITATIVE STRATEGIES LP | 127,091 | $332,978 | 0.04% |